Price
Financials
Standalone, Rs crore| Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.60 | 3.01 | 2.31 | 0.61 | 0.40 | 0.40 | 0.04 | 0.75 | 0.16 | 0.05 | 0.00 | 0.00 |
| Expenses | 2.83 | 1.96 | 2.53 | 1.14 | 1.19 | 11.52 | 0.27 | 4.23 | 1.49 | 0.04 | 0.01 | 0.00 |
| Operating Profit | -0.23 | 1.05 | -0.22 | -0.53 | -0.79 | -11.12 | -0.23 | -3.48 | -1.33 | 0.01 | -0.01 | 0.00 |
| OPM % | -8.85% | 34.88% | -9.52% | -86.89% | -197.50% | -2,780.00% | -575.00% | -464.00% | -831.25% | 20.00% | ||
| Other Income | 0.00 | 0.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.02 | -2.81 | 0.01 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.14 | 1.23 | 0.09 | 0.09 | 0.09 | 1.14 | 0.27 | 0.30 | 0.15 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.37 | 0.30 | -0.31 | -0.62 | -0.88 | -12.33 | -0.49 | -3.78 | -1.46 | -2.80 | 0.00 | 0.00 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| Net Profit | -0.36 | 0.30 | -0.31 | -0.62 | -0.88 | -12.33 | -0.49 | -3.78 | -1.46 | -2.80 | 0.00 | 0.00 |
| EPS in Rs | -0.06 | 0.05 | -0.05 | -0.11 | -0.15 | -2.13 | -0.08 | -0.65 | -0.25 | -0.48 | 0.00 | 0.00 |
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 18.99 | 20.68 | 24.31 | 28.34 | 25.31 | 19.44 | 12.28 | 12.17 | 11.15 | 3.72 | 0.99 | 0.21 |
| Expenses | 16.60 | 19.31 | 22.05 | 25.66 | 22.76 | 20.21 | 11.22 | 11.64 | 9.83 | 21.48 | 5.85 | 1.54 |
| Operating Profit | 2.39 | 1.37 | 2.26 | 2.68 | 2.55 | -0.77 | 1.06 | 0.53 | 1.32 | -17.76 | -4.86 | -1.33 |
| OPM % | 12.59% | 6.62% | 9.30% | 9.46% | 10.08% | -3.96% | 8.63% | 4.35% | 11.84% | -477.42% | -490.91% | -633.33% |
| Other Income | 0.07 | 0.26 | 0.04 | 0.35 | 0.27 | 1.95 | -0.01 | 0.19 | 0.62 | 0.00 | -2.78 | -2.78 |
| Interest | 0.54 | 0.93 | 1.17 | 1.25 | 2.14 | 1.04 | 0.09 | 0.02 | 1.30 | 0.12 | 0.00 | 0.00 |
| Depreciation | 1.43 | 1.62 | 1.68 | 1.68 | 0.67 | 0.82 | 0.70 | 0.70 | 1.48 | 1.41 | 0.00 | 0.15 |
| Profit before tax | 0.49 | -0.92 | -0.55 | 0.10 | 0.01 | -0.68 | 0.26 | 0.00 | -0.84 | -19.29 | -7.64 | -4.26 |
| Tax % | 2.04% | 2.17% | 0.00% | 50.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||
| Net Profit | 0.48 | -0.95 | -0.55 | 0.05 | 0.02 | -0.68 | 0.26 | 0.00 | -0.85 | -19.29 | -7.64 | -4.26 |
| EPS in Rs | 0.11 | -0.19 | -0.11 | 0.01 | 0.00 | -0.13 | 0.05 | 0.00 | -0.15 | -3.33 | -1.32 | -0.73 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | -26% | -45% | -57% | -87% | ||
| Compounded Profit Growth | % | % | % | 92% | ||
| Stock Price CAGR | -18% | -1% | % | % | ||
| Return on Equity | % | % | % | % |
| Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Sep 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8.90 | 10.05 | 10.05 | 10.05 | 10.12 | 11.28 | 10.12 | 10.12 | 11.60 | 11.60 | 11.60 | 11.60 |
| Reserves | 5.67 | 4.35 | 4.34 | 5.04 | 3.98 | 7.12 | 4.28 | 4.28 | 4.08 | -15.17 | -22.81 | -22.81 |
| Borrowings | 3.51 | 7.97 | 8.04 | 11.26 | 22.94 | 21.99 | 21.48 | 18.93 | 20.19 | 20.77 | 12.51 | 12.51 |
| Other Liabilities | 10.03 | 7.66 | 9.70 | 11.88 | 21.89 | 9.90 | 7.41 | 5.63 | 3.33 | 6.08 | 5.55 | 5.55 |
| Total Liabilities | 28.11 | 30.03 | 32.13 | 38.23 | 58.93 | 50.29 | 43.29 | 38.96 | 39.20 | 23.28 | 6.85 | 6.85 |
| Fixed Assets | 8.79 | 10.08 | 8.43 | 6.94 | 16.48 | 15.61 | 14.99 | 14.29 | 11.86 | 10.52 | 0.00 | 0.00 |
| CWIP | 1.77 | 0.00 | 0.00 | 5.21 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.08 | 0.21 | 0.21 | 2.01 | 2.01 | 2.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 17.55 | 19.95 | 23.62 | 25.87 | 42.24 | 32.67 | 26.29 | 22.66 | 27.34 | 12.76 | 6.85 | 6.85 |
| Total Assets | 28.11 | 30.03 | 32.13 | 38.23 | 58.93 | 50.29 | 43.29 | 38.96 | 39.20 | 23.28 | 6.85 | 6.85 |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | -0.20 | 2.22 | -1.53 | 0.39 | 2.29 | -1.82 | -1.11 | 0.64 | -0.41 | -0.82 | 0.51 | -7.34 |
| Cash from Investing Activity | 0.03 | -2.00 | -1.13 | -0.08 | -5.49 | -4.77 | -1.17 | -0.08 | -0.05 | 0.00 | -0.07 | 10.52 |
| Cash from Financing Activity | 0.66 | -1.05 | 4.15 | -0.67 | 2.23 | 7.17 | 2.02 | -0.67 | 0.02 | 0.84 | -0.46 | -3.19 |
| Net Cash Flow | 0.49 | -0.83 | 1.49 | -0.36 | -0.97 | 0.58 | -0.26 | -0.11 | -0.44 | 0.02 | -0.02 | -0.01 |
| Free Cash Flow | -0.28 | 0.22 | -2.67 | 0.37 | -3.11 | -6.62 | -2.29 | 0.64 | -0.41 | -0.82 | 0.44 | 3.18 |
| CFO/OP | 93% | -112% | 17% | 85% | -71% | 144% | 60% | -77% | -62% | -3% | 151% |
| Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 204.47 | 202.01 | 147.20 | 141.74 | 136.52 | 302.56 | 162.79 | 155.15 | 100.77 | 103.77 | 492.55 | 1,585.35 |
| Inventory Days | 90.22 | 121.48 | 168.09 | 148.95 | 165.67 | 320.96 | 392.04 | 972.97 | 901.25 | 1,426.82 | 106.08 | 0.00 |
| Days Payable | 217.10 | 235.49 | 152.62 | 168.67 | 179.59 | 433.53 | 193.36 | 312.47 | 121.83 | 121.67 | 95.58 | |
| Cash Conversion Cycle | 77.59 | 88.00 | 162.68 | 122.01 | 122.60 | 189.98 | 361.46 | 815.66 | 880.19 | 1,408.92 | 503.06 | 1,585.35 |
| Working Capital Days | 185.26 | 75.15 | 67.42 | 81.23 | 69.81 | 37.21 | 59.52 | 82.93 | 150.86 | 295.27 | -766.30 | -2,978.99 |
| ROCE % | -7.17% | 7.04% | 0.05% | 2.77% | 5.54% | 6.78% | 0.93% | 0.92% | 0.06% | 1.33% | -72.24% | -51.35% |
| Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 31.16% | 31.16% | 31.16% | 31.16% | 31.16% | 31.16% | 31.16% | 31.16% | 31.16% | 31.16% | 31.16% | 31.16% |
| Public | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% | 68.83% |
| No. of Shareholders | 6,937 | 6,910 | 6,913 | 6,904 | 6,920 | 6,931 | 6,934 | 6,934 | 6,934 | 6,934 | 6,934 | 6,934 |
Fundamentals
Market Cap₹ 4.87 Cr.
Current Price₹ 0.84
Book Value₹ -1.93
ROCE-51.4 %
ROE%
Dividend Yield0.00 %
Face Value₹ 2.00
Compounded Sales Growth (TTM)-87%
Compounded Profit Growth (TTM)92%
Standalone figures.
Valuation
P/B, 3-year average-1.29x
P/E, 5-year average175.69x
P/B, 5-year average0.81x
Profitability
Operating margin (excl. other income)-490.91%
Operating margin (incl. other income)-771.72%
EBITDA margin-771.72%
Pre-tax margin-771.72%
Net profit margin-771.72%
ROE103.38%
ROCE-82.59%
ROA-50.71%
ROE, 3-year average-73.62%
ROCE, 3-year average-51.17%
ROA, 3-year average-38.21%
ROE, 5-year average-54.82%
ROCE, 5-year average-38.15%
ROA, 5-year average-28.52%
ROIC (approx.)-601.57%
Other income / net worth24.80%
Growth
Sales growth (latest year)-73.39%
Sales CAGR, 3 years-56.67%
Sales CAGR, 5 years-44.87%
Per share
EPS (TTM)Rs -1.32
EPS, 3-year averageRs -1.74
EPS, 5-year averageRs -1.14
Book value per shareRs -1.93
Sales per shareRs 0.17
Cash flow per shareRs -1.27
Free cash flow per shareRs 0.55
Efficiency
Asset turnover0.14x
Debtor days1585 days
Debtors turnover0.23x
Creditor days96 days
Cash conversion cycle1585 days
Working capital days-2979 days
Leverage
Total debtRs 13 Cr
Cash and bankRs 0 Cr
Net debtRs 12 Cr
Debt to equity-1.12x
Owners' fund to total sources-163.65%
Debt to assets182.63%
Cash flow
Cash from Operating Activity (latest year)Rs -7 Cr
Cash from Investing Activity (latest year)Rs 11 Cr
Cash from Financing Activity (latest year)Rs -3 Cr
Net Cash Flow (latest year)Rs -0 Cr
Free cash flow (latest year)Rs 3 Cr
FCFE (approx.: FCF + change in debt)Rs -5 Cr
Statement figures
Net sales (TTM)Rs 1 Cr
Net sales (latest year)Rs 1 Cr
Operating profit excl. other income (latest year)Rs -5 Cr
Operating profit (latest quarter)Rs -0 Cr
Other income (TTM)Rs -3 Cr
EBITDA (TTM)Rs -8 Cr
PBDT (TTM)Rs -8 Cr
Profit before tax (TTM)Rs -8 Cr
Net profit (TTM)Rs -8 Cr
Net profit (latest year)Rs -8 Cr
Cost of goods sold (latest year)Rs 6 Cr
Total expenditure (latest year)Rs 6 Cr
Total income (latest year)Rs -2 Cr
Share capitalRs 12 Cr
ReservesRs -23 Cr
Shareholders' fundsRs -11 Cr
Total assetsRs 7 Cr
ReceivablesRs 4 Cr
Other liabilitiesRs 6 Cr
Shares outstanding (crore)5.80
Ownership
Promoter holding31.16% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
Not enough price history.
Red flags
F-score 2 of 8| serious | Negative equity Shareholders' equity is negative |
| explain | Receivables outrunning sales Receivables grew -14% vs sales -73% in 2021 |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Sep 2021Sales ₹0 Cr -100.0% vs Sep 2020.
Net profit ₹0 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Maximaa Systems Ltd?
Maximaa Systems Ltd (526538) has a market capitalisation of Rs 4.87 Cr. at the close.
What were Maximaa Systems Ltd's latest quarterly results?
In the Sep 2021 quarter, Maximaa Systems Ltd sales was Rs 0 Cr (-100.0% vs Sep 2020) and net profit was Rs 0 Cr.